Infectious Disease · Neurology
The facts most likely to be tested
Botulism is caused by the Clostridium botulinum neurotoxin, which irreversibly binds to presynaptic membranes and inhibits the release of acetylcholine at the neuromuscular junction.
The classic clinical presentation is descending flaccid paralysis starting with cranial nerve palsies such as diplopia, dysphagia, and dysarthria.
Infant botulism is associated with the ingestion of honey containing spores, leading to floppy baby syndrome, constipation, and poor feeding.
Foodborne botulism is classically linked to the consumption of improperly canned foods or vacuum-packed items containing the preformed toxin.
Wound botulism is a critical consideration in patients with a history of intravenous drug use, particularly black tar heroin injection.
The diagnosis of botulism is primarily clinical, but confirmation is achieved by detecting the toxin in the patient's serum, stool, or implicated food source.
The definitive treatment for botulism is the immediate administration of equine heptavalent botulinum antitoxin without waiting for laboratory confirmation.
Vignette unlocked
A 4-month-old infant is brought to the emergency department by his parents due to three days of increasing lethargy and poor feeding. The mother notes that the infant has been unusually constipated and has had a weak cry. On physical examination, the infant exhibits generalized hypotonia, ptosis, and diminished gag reflex. The parents report introducing honey into the infant's diet one week ago.
What is the most appropriate next step in management?
Administration of human-derived botulism immune globulin (BIG-IV)
This vignette tests the recognition of infant botulism, which is treated with human-derived BIG-IV rather than the equine antitoxin used for adults to avoid hypersensitivity reactions.
Full handout
High yield triage
Etiology / Epidemiology
Caused by Clostridium botulinum neurotoxin. Risk factors: home-canned foods (adults) or honey (infants).
Clinical Manifestations
Presents as descending flaccid paralysis. Look for diplopia, dysphagia, and fixed dilated pupils.
Diagnosis
Clinical diagnosis confirmed by serum toxin assay via mouse bioassay or PCR.
Treatment
Administer botulinum antitoxin immediately. Do not wait for lab confirmation.
Prognosis
Recovery takes weeks to months. Respiratory failure is the primary cause of mortality.
Full handout
Epidemiology & Etiology
Foodborne botulism results from ingestion of preformed toxin in improperly canned foods. Infant botulism occurs via ingestion of Clostridium botulinum spores (often in honey), which colonize the gut. Wound botulism is associated with IV drug use and deep tissue abscesses.
Pertinent Anatomy
The toxin acts at the neuromuscular junction and autonomic synapses. It specifically targets the presynaptic cholinergic nerve terminals to prevent neurotransmitter release.
Pathophysiology
The toxin irreversibly binds to the presynaptic membrane, preventing the release of acetylcholine. This leads to a blockade of neuromuscular transmission, resulting in flaccid paralysis. The process is characterized by a descending pattern of motor weakness.
Clinical Manifestations
Initial symptoms include diplopia, dysarthria, and dysphagia. Physical exam reveals fixed, dilated pupils and descending paralysis. Respiratory failure is the most critical complication requiring immediate intubation.
Diagnosis
Diagnosis is primarily clinical. The gold standard is the mouse bioassay to detect toxin in serum, stool, or gastric aspirate. Electromyography may show incremental response to repetitive nerve stimulation.
Treatment
Administer heptavalent botulinum antitoxin (HBAT) as soon as clinical suspicion arises. Do not administer aminoglycosides as they potentiate the neuromuscular blockade. Supportive care, including mechanical ventilation, is the cornerstone of management.
Prognosis
Recovery is slow, requiring regeneration of nerve terminals. Respiratory failure and secondary infections are the leading causes of death. Patients require prolonged ICU monitoring for respiratory status.
Differential Diagnosis
Guillain-Barre Syndrome: Ascending paralysis with elevated CSF protein
Myasthenia Gravis: Fluctuating weakness, improves with rest
Lambert-Eaton Syndrome: Proximal muscle weakness, improves with use
Tick Paralysis: Ascending paralysis, resolves upon tick removal
Stroke: Usually unilateral, sudden onset, sparing of pupillary reflexes